Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium

Autor: Pearce, CL, Near, AM, Van Den Berg, DJ, Ramus, SJ, Gentry-Maharaj, A, Menon, U, Gayther, SA, Anderson, AR, Edlund, CK, Wu, AH, Chen, X, Beesley, J, Webb, PM, Holt, SK, Chen, C, Doherty, JA, Rossing, MA, Whittemore, AS, McGuire, V, DiCioccio, RA, Goodman, MT, Lurie, G, Carney, ME, Wilkens, LR, Ness, RB, Moysich, KB, Edwards, R, Jennison, E, Kjaer, SK, Hogdall, E, Hogdall, CK, Goode, EL, Sellers, TA, Vierkant, RA, Cunningham, JC, Schildkraut, JM, Berchuck, A, Moorman, PG, Iversen, ES, Cramer, DW, Terry, KL, Vitonis, AF, Titus-Ernstoff, L, Song, H, Pharoah, PDP, Spurdle, AB, Anton-Culver, H, Ziogas, A, Brewster, W, Galitovskiy, V, Chenevix-Trench, G, Gertig, D, Vanden Bergh, T, Camaris, C, Crouch, R, Edwards, L, Hacker, N, Marsden, D, Robertson, G, DeFazio, A, Hung, J, Chiew, YE, Stenlake, A, Sullivan, H, Brand, A, Jaworski, R, Harnett, P

Publikováno v: Pearce, CL; Near, AM; Van Den Berg, DJ; Ramus, SJ; Gentry-Maharaj, A; Menon, U; et al.(2009). Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. British Journal of Cancer, 100(2), 412-420. doi: 10.1038/sj.bjc.6604820. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/8438f765

The search for genetic variants associated with ovarian cancer risk has focused on pathways including sex steroid hormones, DNA repair, and cell cycle control. The Ovarian Cancer Association Consortium (OCAC) identified 10 single-nucleotide polymorph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::5162772c28833e756f69bc70a772b64b
http://www.escholarship.org/uc/item/8438f765

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.

Autor: Pearce CL (AUTHOR), Templeman C (AUTHOR), Rossing MA (AUTHOR), Lee A (AUTHOR), Near AM (AUTHOR), Webb PM (AUTHOR), Nagle CM (AUTHOR), Doherty JA (AUTHOR), Cushing-Haugen KL (AUTHOR), Wicklund KG (AUTHOR), Chang-Claude J (AUTHOR), Hein R (AUTHOR), Lurie G (AUTHOR), Wilkens LR (AUTHOR), Carney ME (AUTHOR), Goodman MT (AUTHOR), Moysich K (AUTHOR), Kjaer SK (AUTHOR), Hogdall E (AUTHOR), Jensen A (AUTHOR)

Publikováno v: Lancet Oncology. Apr2012, Vol. 13 Issue 4, p385-394. 10p.

Excess healthcare resource utilization and costs for commercially insured patients with pulmonary arterial hypertension: A real-world data analysis.

Autor: Weiss T; Merck & Co., Inc. Rahway New Jersey USA., Ramey DR; Merck & Co., Inc. Rahway New Jersey USA., Pham N; IQVIA Inc. Durham North Carolina USA., Shaikh NF; IQVIA Inc. Durham North Carolina USA., Tian D; IQVIA Inc. Durham North Carolina USA., Zhao X; IQVIA Inc. Durham North Carolina USA., Near AM; IQVIA Inc. Durham North Carolina USA., Lautsch D; Merck & Co., Inc. Rahway New Jersey USA., Nathan SD; Inova Fairfax Hospital Falls Church Virginia USA.

Publikováno v: Pulmonary circulation [Pulm Circ] 2024 Jun 19; Vol. 14 (2), pp. e12390. Date of Electronic Publication: 2024 Jun 19 (Print Publication: 2024).

Real-world costs of obesity-related complications over eight years: a US retrospective cohort study in 28,500 individuals.

Autor: Pearson-Stuttard J; Lane Clark & Peacock LLP, London, UK. Jonathan.Pearson-Stuttard@lcp.uk.com.; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. Jonathan.Pearson-Stuttard@lcp.uk.com., Banerji T; IQVIA, Durham, NC, USA., Capucci S; Novo Nordisk A/S, Søborg, Denmark., de Laguiche E; Novo Nordisk A/S, Søborg, Denmark., Faurby MD; Novo Nordisk A/S, Søborg, Denmark., Haase CL; Novo Nordisk A/S, Søborg, Denmark., Sommer Matthiessen K; Novo Nordisk A/S, Søborg, Denmark., Near AM; IQVIA, Durham, NC, USA., Tse J; IQVIA, Durham, NC, USA., Zhao X; IQVIA, Durham, NC, USA., Evans M; University Hospital, Llandough, Penarth, Cardiff, UK.

Publikováno v: International journal of obesity (2005) [Int J Obes (Lond)] 2023 Dec; Vol. 47 (12), pp. 1239-1246. Date of Electronic Publication: 2023 Sep 18.

Weight gain following switch to integrase inhibitors from non-nucleoside reverse transcriptase or protease inhibitors in people living with HIV in the United States: analyses of electronic medical records and prescription claims.

Autor: Tse J; Real World Solutions, IQVIA, Durham, NC, USA., Prajapati G; Merck & Co., Inc, Rahway, NJ, USA., Zhao X; Real World Solutions, IQVIA, Durham, NC, USA., Near AM; Real World Solutions, IQVIA, Durham, NC, USA., Kumar PN; Georgetown University Medical Center, Washington, DC, USA.

Publikováno v: Current medical research and opinion [Curr Med Res Opin] 2023 Sep; Vol. 39 (9), pp. 1237-1246. Date of Electronic Publication: 2023 Aug 10.